MetaADEDB 2.0 @ LMMD
Metastases to pelvis
(UMLS:C3160764)
UMLS ID:
C3160764
MeSH ID:
N/A
Synonym(s)
1.
Metastases to pelvis
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1Erlotinib HydrochlorideFAERS: 9US FAERS
2Erlotinib HydrochlorideFAERS: 6US FAERS
3Imatinib MesylateFAERS: 4US FAERS
4Zoledronic AcidFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
5olaparibFAERS: 4US FAERS
6EverolimusFAERS: 3US FAERS
7pazopanibFAERS: 3US FAERS
8Imatinib MesylateFAERS: 2US FAERS
9LetrozoleFAERS: 2US FAERS
10OctreotideFAERS: 2US FAERS
11osimertinibFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
12regorafenibFAERS: 2US FAERS
13AlendronateFAERS: 1US FAERS
14CH5424802FAERS: 1US FAERS
15CapecitabineFAERS: 1US FAERS
16DexlansoprazoleFAERS: 1US FAERS
17FulvestrantFAERS: 1US FAERS
18MDV 3100FAERS: 1US FAERS
19NorgestrelFAERS: 1US FAERS
20PamidronateFAERS: 1US FAERS
21PamidronateFAERS: 1US FAERS
22SorafenibFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
23ThyroxineFAERS: 1US FAERS
24Tiotropium BromideFAERS: 1US FAERS
25VemurafenibFAERS: 1US FAERS
26carbidopa, levodopa drug combinationFAERS: 1US FAERS
27ceritinibFAERS: 1US FAERS
28paricalcitolFAERS: 1US FAERS
29pazopanibFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
30OctreotideCanada Vigilance: 1Canada Vigilance
31TamoxifenCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.